Skip to content

A clinical study on the management of Takkul-e-Unqur-Rahem(cervical erosion) with Marham-e-Raal as a topical medicine- An Open Label single Arm Study.

A clinical Study to Evaluate the Efficacy of Marham-e-Raal As topical medicine in The Management of Takkul-e-Unqur-Rahem(Cervical Erosion)-An Open Label single Arm Study. - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086083
Enrollment
30
Registered
2025-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Intervention1: Ointment of a Unani polyherbal formulation: Ointment Marham e Raal procure from Dehlvi Company. A GMP certified Unani formulation will be applied locally once a day at night for 14 days

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Married Sexually Active Women s in age group of 18 to 45 years having vaginal discharge. 2) Patients with complaints of excess vaginal discharge, dull pelvic pain, contact bleeding/post coital bleeding, dyspareunia, lower backache, dysuria. 3) Patients with normal or inflammatory changes in pap smear. 4) Patients on examination: P/S:- cervix will be red, edematous and having slightly raised area around external os. Which is smooth or glistening. White or yellowish mucopurulent discharge in the vagina. Cervix may be normal or bulky or with findings like Nabothian follicle. P/V:- cervix will be firm and erosion site may give velvety feel to the examining finger and it may bleed easily.

Exclusion criteria

Exclusion criteria: 1) Patients having STD s (AIDS, syphilis), systemic illness like cardiovascular disease, diabetes mellitus, renal disease, liver disease, coagulation disorder. 2)Those patients with abnormal pap smear findings like having malignancies, or with frank growth on cervix, steroidal contraceptives and IUCDS.{having Cervical cancer, Cervical polyps} 3) Pregnant or lactating women s were also excluded from the study. 4) Unmarried women, or with age of less than 18 years or more than 45 years. 5) Individuals with alcohol or any other substance abuse.

Design outcomes

Primary

MeasureTime frame
1.Improvement in the subjective parameters such as vaginal discharge,lower backache,dyspareunia,contact bleeding or post coital bleeding in response to the treatment. 2.Improvement in PS and PV examination in response to the treatment.Timepoint: 1.Assessment of the subjective parameters at baseline,7th,15th and 45th day. 2.Assessment of the objective parameters at baseline and 45th day.

Secondary

MeasureTime frame
1.Improvement in grading of Cervical erosion in response to the treatment.Timepoint: 1.Assessment of grading of Cervical erosion at baseline & 45th day.

Countries

India

Contacts

Public ContactHajra Zareen

Ayurvedic and Unani Tibbia College and Hospital, Karol Bagh, New Delhi

shahanaayub86@gmail.com7037881205

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026